Skip to main content
Experimental and Therapeutic Medicine logoLink to Experimental and Therapeutic Medicine
. 2021 May 18;22(1):772. doi: 10.3892/etm.2021.10204

The importance of adrenal venous sampling in ACTH-independent Cushing syndrome: A case report and literature review

Raluca Tulin 1,2, Adrian Tulin 3,4,, Luminita Florentina Tomescu 5, Enyedi Mihaly 3, Adelaida Avino 6,7, Bogdan Socea 8,9, Cristian-Radu Jecan 6,7, Ovidiu Stiru 10,11, Radu-Iulian Spataru 12,13
PMCID: PMC8145433  PMID: 34055071

Abstract

Independent Cushing's adrenocorticotropic hormone (ACTH) syndrome can have several causes, including adrenal carcinoma or simple adrenal hyperplasia. Although the distinction between malignant and benign can be effectively made through imaging investigations, in the situation where there are bilateral formations, their hormonal activity is impossible to appreciate via non-invasive techniques. The present study includes the presentation of a clinical case on the basis of which a literature review was made. The clinical case pertains to a 32-year-old patient with ACTH-independent Cushing's syndrome and bilateral adrenal tumor formations leading to the utility of adrenal venous sampling to avoid bilateral adrenalectomy. A literature review was subsequently conducted focusing on articles pertaining to the PICO criteria in order to describe: The diagnosis of adrenal tumor masses, the decision on the type of surgery and most importantly, the impact of adrenal venous sampling in avoiding surgical resection. These interventions severely limit the patients' quality of life.

Keywords: Cushing's syndrome, suprarenal vein catheterization, decision-making

Introduction

Cushing's syndrome (CS) is considered a rare and challenging disorder (1,2). It can be classified by the level of adrenocorticotropic hormone (ACTH) in two major subtypes: ACTH-independent with autonomous production of corticoid hormones, and ACTH-dependent with peripheral hyperproduction of corticoid hormones which is dictated by the pituitary gland through hypersecretion of ACTH (3). It is highly important to exclude exogenous causes, more specifically the administration of steroid hormones. There are three major situations which lead to CS: Adrenal adenomas, adrenal carcinomas, and adrenal hyperplasia, excluding a pituitary origin of the syndrome (4,5).

In all these situations, the standard treatment is surgical resection of the adenomatous gland when there is unilateral involvement or bilateral suprarenalectomy, when both glands have functional active adenomas (6). Bilateral adrenalectomy is associated with a decrease in the patient's quality of life, requiring mineralocorticoid and glucocorticoid replacement therapy. Therefore, effective investigations are crucial to diagnose preoperatively the origin of hyperproduction of the adrenal gland. The computed tomography scan can identify bilateral adrenal adenomas, with three possible scenarios: Hyperproductive bilateral cortisol tumors, adrenal macronodular hyperplasia or hyperproductive unilateral cortisol tumor, and a non-functional contralateral tumor (6). In the case that primary hyperaldosteronism adenoma is suspected, adrenal scintigraphy is considered a safe and effective diagnostic solution (7).

Currently, the gold standard diagnostic tool for patients with bilateral adrenal adenoma and ACTH-independent CS is bilateral adrenal venous sampling and the dosage of cortisol levels. Value comparison provides definitive results in 99.9% of cases (8). This diagnostic procedure is an invasive one that involves a number of risks for the patient and limitations for the physician. The method is based on left adrenal vein cannulation which is difficult intervention due to the fact that the vein is often narrow with a sinuous route being difficult to locate.

Research methods

This paper exemplifies the importance of this diagnostic procedure through a clinical case described in the next paragraph. To perform a pertinent review of the literature on the described topic, successive searches were obtained from the PubMed database between 1 January, 1995 and 1 October, 2020 using the keywords: ‘Adrenal vein sampling’ AND ‘adrenal mass imaging’ AND ‘ACTH non-dependent Cushing syndrome’. The search was refined for original articles and rare clinical cases written only in English. A total of 43 articles were identified. After manual selection that met the PICO criteria, 13 articles were eliminated as such: Incomplete data (4 articles), 7 articles did not have the full text available and 2 articles did not incorporate a study on bilateral suprarenal adenomas and as such were not introduced in the analysis. A total of 30 articles were selected and 22 were selected for discussion, which will be described in detail subsequently in the study.

The study was conducted according to the World Medical Association Declaration of Helsinki, using a protocol approved by the local Bioethics Committee from ‘Prof. Dr. Agrippa Ionescu’ Clinical Emergency Hospital (Bucharest, Romania). The patient previously signed informed written consent about hospitalization, treatment and a future publication of data.

Case presentation

This is the case of a 32-year-old female patient who presented to the hospital for progressive weight gain over the previous 6 months. The clinical examination identified an abdominal distribution of adipose tissue, cutaneous fragility, stretch marks on the abdomen and lower limbs, hirsutism, and oligomenorrhea.

Common laboratory tests confirmed the presence of leukocytosis with neutrophilia and hypoglycemia (unusual), hypercholesterolemia and D-vitamin insufficiency, which are characteristic (9).

The hormonal profile was obtained: Blood cortisol values, 23.05 µg/dl (6.7-22.6); cortisol values at 24:00 h, 4.56 µg/dl. The circadian rate of cortisol hormone secretion was maintained. ACTH value was 1.21 pg/ml and urinary free cortisol (UFC) value was 1,448 nmol/24 h [52.48 µg/dl]. The values obtained after the 1 mg overnight dexamethasone test were: Cortisol, 10.47 µg/dl [288.9 nmol/l]; follicle-stimulating hormone (FSH), 5.72 mUI/ml; luteinizing hormone (LH), 6.04 mUI/ml; estradiol, 28.6 pg/ml and prolactin (PRL), 13.16 ng/ml, indicating intact hypophyseal ovarian axis. Osteopenia was also confirmed.

After the 24-h blood pressure monitoring was performed, the presence of a dipper profile was confirmed: The average diurnal value was 126/80 mmHg and nocturnal value of 100/71 mmHg.

A glucose tolerance test was performed which revealed glycemia value of 75 mg/dl at 2 h. Echocardiography excluded the presence of atrial myxoma or other cardiovascular abnormalities.

The abdominal contrast-enhanced computed tomography scan showed nodular lesions in the adrenal glands-7 mm on the right and 37 mm on the left which were probably adenoids with low lipid substrate (32 HU-Hounsfield unit densities) (Fig. 1).

Figure 1.

Figure 1

Abominal CT with IV contrast: Similar nodular lesions in both of the adrenal glands were identified.

Subsequent head magnetic resonance imaging showed the hypophysis with low 3-4 mm hypocaptant areas in the right and left adenohypophysis with non-homogeneous loading with intravenous contrast (possibly suggesting microadenomas).

The diagnosis of an ACTH-independent CS was confirmed due to adrenal adenomas.

In order to accurately identify the hyperproductive adenoma for surgical resection, supra-selective hormone dosage from both of the suprarenal veins was obtained and the lateralization index was calculated. Firstly, the right femoral vein was used as an entry point, after that the right suprarenal vein was catheterized followed by the left suprarenal vein and blood samples for hormone dosage were obtained (Fig. 2).

Figure 2.

Figure 2

Radiologic aspect during catheterization of the suprarenal veins.

The following cortisol values were confirmed: Right adrenal vein, 5.91 µg/dl and left adrenal vein, >60 µg/dl. These values confirmed the ACTH-independent CS due to a left adrenal adenoma. Surgery was decided and a left laparoscopic adrenalectomy was performed in January, 2018 (Table I).

Table I.

Postoperative cortisol values.

Date Cortisol (133-537 nmol/l)
02.2018 8 nmol/l=0.28 µg/dl
02.2018 106.3 nmol/l=3.85 µg/dl
03.2018 141.7 nmol/l=5.13 µg/dl
03.2018 148.4 nmol/l=5.37 µg/dl
04. 2018 272.2 nmol/l=9.86 µg/dl
05.2018 Stop Prednisone 360 nmol/l=13.04 µg/dl

The 1-year follow-up was favorable. The patient was started on supplements with vitamin D and the osteoporosis was recovered completely.

Current diagnostic criteria and surgical treatment options

The use of high-resolution imaging has led to an increased rate of incidental detection of unilateral adrenal masses, which most commonly are benign non-functioning adrenal adenomas. Patients with bilateral adrenal masses are rarely encountered. Patients with bilateral adrenal tumors can present different clinical manifestations ranging from asymptomatic to multi-organ dysfunctions (10).

In the patient with ACTH-independent Cushing's syndrome, CT examination is the initial imaging procedure with first intention. Abdominal MRI should be conducted when there is ambiguity as it is not cost-effective. A retrospective study that included 99 patients (48 women and 51 men) reported the imaging characteristics of their 122 adrenal masses (10). Patients were either operated on to obtain a tissue sample from the tumors or were enrolled in a follow-up program with regular CT evaluations (10). CT scan images were recorded from all the patients, both native (without intravenous contrast substance) and after administration of 120 ml of intravenous contrast substance (10). Subsequently, the images were analyzed after mean attenuation, calculating relative percentage washout (RPW) and absolute percentage washout (APW) (10).

The specificity and sensitivity of identifying malignant tumors with these criteria were 98 and 100%, respectively. The attenuation of 43 HU was used as the threshold to distinguish benign from malignant lesions. Thus, the surgical approach must be guided by imaging suspicion (10).

Adrenal hyperplasia is a common cause of this disease (11). This is followed by infection, metastasis or lymphoma, while bilateral tumors usually evolve as pheochromocytomas (12,13). Tian et al highlighted the etiologies of bilateral adrenal lesions in a study performed on 260 patients. Authors of that study showed that bilateral adrenal hyperplasia was identified in 75 cases, followed in frequency by bilateral adrenal adenomas, metastatic carcinoma, discordant bilateral adrenal lesions, bilateral pheochromocytomas, among others. A mere 5 patients were diagnosed with CS which consisted of only 2% of all cases (12). Zhou et al described in their study 18 patients with bilateral adrenal masses from 565 patients with adrenal tumors. Of the 18 patients, only 1 patient presented CS (14).

The therapeutic management of patients with bilateral adrenal masses and CS is challenging for the endocrinologist, but also for the general surgeon. Surgical excision of the adrenal glands must be avoided in the absence of a certain diagnosis. Macronodular bilateral adrenal hyperplasia in a patient with ACTH-independent Cushing syndrome is one of the rarest causes of cortisol hyperproduction (5).

When a patient is diagnosed with bilateral adrenal masses, it is crucial to determine whether both have hormonal activity. High-resolution imaging does not bring important data regarding the differentiation between a hyper-functional adenoma and a non-functional one. Direct hormonal dosing from the adrenal vein has been reported as an effective way to differentiate these tumor masses in ACTH-independent Cushing syndrome (15).

Less than 2% of all cases of hypercorticism exist in the form of two concomitant adrenal mass tumors, therefore the possibility that only one of the tumors was responsible for the Cushing syndrome was high in our patient (16).

However, improvements have been made and The Society of Endocrinology recommends ultra-selective hormone dosage of blood obtained directly from both the adrenal veins as a standard diagnostic technique when such cases are encountered (5). However, few studies have described the utility and effectiveness of this technique. The vast majority of published articles on this subject are case studies, while major prospective randomized trials are lacking.

However, Funder et al demonstrated the effectiveness of this diagnostic technique, using a relatively small batch of only 10 patients. Their study made a reference to the threshold values for cortisol dosage. Thus the ratio between cortisol values from the adrenal vein (AV) and peripheral vein (PV) >6.5 is highly suggestive of a hyperproductive adenoma, whereas a ratio value <3.3 is consistent with the presence of a non-functional nodule. Regarding the percentage of lateralization, those authors identified that the presence of a gradient >2.3 suggests the presence of a unilateral hyperfunctional tumor while the presence of a gradient ≤2 raises the suspicion of hyperproductive bilateral nodules (16).

The results of this groundbreaking study have recently been questioned by Acharya et al (17) who, using criteria of Funder et al (16), failed to confirm the lateralization of adrenal adenomas, probably due to patient selection criteria as mentioned in the study (17). Instead, the group focused on the morphology identified at the computer tomography scan, and surgically excised accordingly the larger suprarenal multinodular gland, thus avoiding a life-altering bilateral suprarenalectomy. The final results were satisfactory. Identical results were obtained and discussed by Iacobone et al (18) and Debillon et al (19). From our point of view, long-term confirmation of the effectiveness of this method is required; however, the authors from the aforementioned studies did not report a proper follow-up. Additionally, it is imperative to study the improvement of the quality of life of the patients (20).

The contraindications of this procedure are coagulation disorders (21), blood hypertension, contrast substance allergy, pregnancy and kidney failure (22). The association between Cushing's syndrome and chronic kidney disease (CKD) is known and accepted by researchers (23), and is presented in many studies. The presence of blood hypertension leads to hypertensive nephrophathy (24,25).

Unilateral adrenal venous sampling has been employed by multiple endocrinology societies as the optimal diagnostic tool when bilateral adenomas are encountered and associated with an ACTH-independent CS (16,26).

Scintigraphy has a limited usage as frequently both of the adenomas capture the tracer and the clinician cannot distinguish which of them needs resecting (27).

In our case, the resection was performed by a multidisciplinary team, which encompassed a general and vascular surgeon. Postoperatively, the parietal wounds after laparoscopy were treated with a gel with polyhexanidine, due to its antiseptic properties (28).

Although the adrenal venous sampling technique is reserved for diagnosis it is nonetheless an invasive procedure. Thus, attention needs to be paid to the possible immediate complications and the medical staff should be prepared if they arise (29).

Complications may be severe, so it is highly important to have a vascular surgery department in the center where the investigation is performed. The complications encountered when this procedure is performed include hemorrhage with retroperitoneal hematoma, adrenal infarction and hematoma at the puncture site (30,31).

The risk of rupturing the adrenal vein during this procedure is <1% (32).

In conclusion, when bilateral adrenal tumors are encountered a differential diagnosis is difficult to obtain. In the case of an associated ACTH-independent Cushing syndrome, scintigraphy has a limited utility. Hormone dosage from venous blood of both adrenal veins is a key step in confirming the presence of a lateral secretion of cortisol. Due to the rarity of this pathology, it would be necessary to have an international database in order to obtain data with the statistical value that would allow optimization of the therapeutic management of these patients. In our case, the intervention was performed by a multidisciplinary team, general and vascular surgeons. Postoperatively, the parietal wounds after laparoscopy were treated with a gel with polyhexanidine, due to its antiseptic properties. Although this technique is reserved for diagnosis it is nonetheless an invasive procedure, and attention should be paid to the possible immediate complications and the medical staff should be prepared if they arise.

Acknowledgements

Not applicable.

Funding Statement

Funding: No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

RT, RIS, CRJ and AT made major contribution to the conception and design of the study. RIS, AA, BS, LFT, AT, EM, CRJ and OS, provided study material or patients, collected the data and analyzed the datasets. RIS, RT, LFT, AA, BS, EM, AT and OS wrote the manuscript. RT, AT, RIS and CRJ confirmed the authenticity of all the raw data and RT, RIS and CRJ critically revised the manuscript. All authors read and approved the final manuscript. The contribution of all the authors on this article is greatly valued and appreciated.

Ethics approval and consent to participate

The study was conducted according to the World Medical Association Declaration of Helsinki, using a protocol approved by the local Bioethics Committee from ‘Prof. Dr. Agrippa Ionescu’ Clinical Emergency Hospital (Bucharest, Romania).

Patient consent for publication

The patient previously signed informed written consent about hospitalization, treatment and a future publication of data.

Competing interests

The authors declare that they have no competing interests.

References

  • 1.Pappachan JM, Hariman C, Edavalath M, Waldron J, Hanna FW. Cushing's syndrome: A practical approach to diagnosis and differential diagnoses. J Clin Pathol. 2017;70:350–359. doi: 10.1136/jclinpath-2016-203933. [DOI] [PubMed] [Google Scholar]
  • 2.Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: Epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281–293. doi: 10.2147/CLEP.S44336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Stewart PM. The adrenal cortex. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds): Williams textbook of endocrinology. 11th edition. Saunders Elsevier, Philadelphia, PH, pp445-503, 2008. [Google Scholar]
  • 4.Dinneen SF, Carney JA, Carpenter PC, Grant CS, Young WF Jr. Acth-independent Cushing's syndrome: Bilateral cortisol-producing adrenal adenomas. Endocr Pract. 1995;1:77–81. doi: 10.4158/EP.1.2.77. [DOI] [PubMed] [Google Scholar]
  • 5.De Venanzi A, Alencar GA, Bourdeau I, Fragoso MC, Lacroix A. Primary bilateral macronodular adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes. 2014;21:177–184. doi: 10.1097/MED.0000000000000061. [DOI] [PubMed] [Google Scholar]
  • 6.Domino JP, Chionh SB, Lmanto D, Katara AN, Rauff A, Cheah WK. Laparoscopic partial adrenalectomy for bilateral cortisol-secreting adenomas. Asian J Surg. 2007;30:154–157. doi: 10.1016/S1015-9584(09)60152-4. [DOI] [PubMed] [Google Scholar]
  • 7.Yasuda A, Seki T, Ito K, Takagi A, Watanabe D, Nakamura N, Hanai K, Terachi T, Maekawa T, Sasano H, Fukagawa M. A rare case of Cushing's syndrome due to bilateral adrenocortical adenomas. Tokai J Exp Clin Med. 2014;39:158–165. [PubMed] [Google Scholar]
  • 8.Stewart PM, Allolio B. Adrenal vein sampling for primary aldosteronism: Time for a reality check. Clin Endocrinol (Oxf) 2010;72:146–148. doi: 10.1111/j.1365-2265.2009.03714.x. [DOI] [PubMed] [Google Scholar]
  • 9.Stanescu AMA, Grajdeanu IV, Iancu MA, Pantea Stoian A, Bratu OG, Socea B, Socea LI, Diaconu CC. Correlation of oral vitamin D administration with the severity of psoriasis and the presence of metabolic syndrome. Rev Chim. 2018;69:1668–1672. [Google Scholar]
  • 10.Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV, Halpern EF, Mueller PR, Hahn PF, Boland GW. Distinguishing benign from malignant adrenal masses: Multi-detector row CT protocol with 10-minute delay. Radiology. 2006;238:578–585. doi: 10.1148/radiol.2382041514. [DOI] [PubMed] [Google Scholar]
  • 11.Lomte N, Bandgar T, Khare S, Jadhav S, Lila A, Goroshi M, Kasaliwal R, Khadilkar K, Shah NS. Bilateral adrenal masses: A single-centre experience. Endocr Connect. 2016;5:92–100. doi: 10.1530/EC-16-0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tian Q, Zhang ST, Gao HW, Lu R, Yang J, Wang HN, Hong TP. The etiological analysis of 260 hospitalized cases with bilateral adrenal lesions. Zhonghua Yi Xue Za Zhi. 2019;99:1246–1250. doi: 10.3760/cma.j.issn.0376-2491.2019.16.011. (In Chinese) [DOI] [PubMed] [Google Scholar]
  • 13.Bratu OG, Marcu RD, Socea B, Neagu TP, Diaconu CC, Scarneciu I, Turcu FL, Radavoi GD, Bratila E, Berceanu C, Spinu AD. Immunohistochemistry particularities of retroperitoneal tumors. Rev Chim. 2018;69:1813–1816. [Google Scholar]
  • 14.Zhou J, Ye D, Wu M, Zheng F, Wu F, Wang Z, Li H. Bilateral adrenal tumor: Causes and clinical features in eighteen cases. Int Urol Nephrol. 2009;41:547–551. doi: 10.1007/s11255-008-9484-y. [DOI] [PubMed] [Google Scholar]
  • 15.Young WF Jr, du Plessis H, Thompson GB, Grant CS, Farley DR, Richards ML, Erickson D, Vella A, Stanson AW, Carney JA, et al. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J Surg. 2008;32:856–862. doi: 10.1007/s00268-007-9332-8. [DOI] [PubMed] [Google Scholar]
  • 16.Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266–3281. doi: 10.1210/jc.2008-0104. Endocrine Society. [DOI] [PubMed] [Google Scholar]
  • 17.Acharya R, Dhir M, Bandi R, Yip L, Challinor S. Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent Cushing's syndrome. World J Surg. 2019;43:527–533. doi: 10.1007/s00268-018-4788-2. [DOI] [PubMed] [Google Scholar]
  • 18.Iacobone M, Albiger N, Scaroni C, Mantero F, Fassina A, Viel G, Frego M, Favia G. The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH) World J Surg. 2008;32:882–889. doi: 10.1007/s00268-007-9408-5. [DOI] [PubMed] [Google Scholar]
  • 19.Debillon E, Velayoudom-Cephise FL, Salenave S, Caron P, Chaffanjon P, Wagner T, Massoutier M, Lambert B, Benoit M, Young J, et al. Unilateral adrenalectomy as a first-line treatment of Cushing's syndrome in patients with primary bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100:4417–4424. doi: 10.1210/jc.2015-2662. [DOI] [PubMed] [Google Scholar]
  • 20.Răducu L, Avino A, Purnichescu Purtan R, Balcangiu-Stroescu AE, Bălan DG, Timofte D, Ionescu D, Jecan CR. Quality of life in patients with surgically removed skin tumors. Medicina (Kaunas) 2020;56(66) doi: 10.3390/medicina56020066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Laslo CL, Pantea Stoian A, Socea B, Paduraru DN, Bodean O, Socea LI, Neagu TP, Stanescu AMA, Marcu D, Diaconu C. New oral anticoagulants and their reversal agents. J Mind Med Sci. 2018;5:195–201. [Google Scholar]
  • 22.Gaman MA, Dobrica EC, Pascu EG, Cozma MA, Epingeac ME, Gaman AM, Pantea Stoian AM, Bratu OG, Diaconu CC. Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity. J Mind Med Sci. 2019;6:157–161. [Google Scholar]
  • 23.Li X, Xiang X, Hu J, Goswami R, Yang S, Zhang A, Wang Y, Li Q, Bi X. Association between serum cortisol and chronic kidney disease in patients with essential hypertension. Kidney Blood Press Res. 2016;41:384–391. doi: 10.1159/000443435. [DOI] [PubMed] [Google Scholar]
  • 24.Mandita A, Timofte D, Balcangiu-Stroescu AE, Balan D, Raducu L, Tanasescu MD, Diaconescu A, Dragos D, Cosconel CI, Stoicescu SM, Ionescu D. Treatment of high blood pressure in patients with chronic renal disease. Rev Chim Buchar. 2019;70:993–995. [Google Scholar]
  • 25.Balcangiu-Stroescu AE, Tanasescu MD, Diaconescu A, Raducu L, Constantin AM, Balan DG, Tarmure V, Ionescu D. Cardiovascular comorbidities, inflammation and serum albumin levels in a group of hemodialysis patients. Rev Chim. 2018;69:926–929. [Google Scholar]
  • 26.Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan endocrine society 2009. Endocr J. 2011;58:711–721. doi: 10.1507/endocrj.ej11-0133. Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. [DOI] [PubMed] [Google Scholar]
  • 27.Oki K, Yamane K, Sakashita Y, Kamei N, Watanabe H, Toyota N, Shigeta M, Sasano H, Kohno N. Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas. Clin Exp Nephrol. 2008;12:382–387. doi: 10.1007/s10157-008-0064-3. [DOI] [PubMed] [Google Scholar]
  • 28.Raducu L, Balcangiu-Stroescu AE, Stanescu II, Tanasescu MD, Cozma CN, Jecan CR, Badita DG. Use of polyhexanidine in treating chronic wounds. Rev Chim. 2017;68:2112–2113. [Google Scholar]
  • 29.Paduraru DN, Scanteie C, Bolocan A, Andronic O, Morar A, Ghervan C, Ciunt R, Socea B, Bratu OG, Dragomir LM, et al. Pasireotide after surgery for persistent Cushing's disease. Mod Med. 2019;26:227–231. [Google Scholar]
  • 30.Marcu RD, Diaconu CC, Constantin T, Socea B, Ionita-Radu F, Mischianu DLD, Bratu OG. Minimally invasive biopsy in retroperitoneal tumors. Exp Ther Med. 2019;18:5016–5020. doi: 10.3892/etm.2019.8020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Marcu DR, Ionita-Radu F, Iorga LD, Manea M, Socea B, Scarneciu I, Isvoranu G, Costache R, Diaconu CC, Bratu OG. Vascular involvement in primary retroperitoneal tumors. Rev Chim. 2019;70:445–448. [Google Scholar]
  • 32.Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, Degenhart C, Deinum J, Fischer E, Gordon R, et al. The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012;97:1606–1614. doi: 10.1210/jc.2011-2830. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Experimental and Therapeutic Medicine are provided here courtesy of Spandidos Publications

RESOURCES